Beam Therapeutics (BEAM) Preferred Dividend Payments (2019 - 2020)

Beam Therapeutics (BEAM) has reported Preferred Dividend Payments for 2 consecutive years, with $1.3 million the latest figure, recorded in Q1 2020.

• In Q1 2020, Preferred Dividend Payments fell 56.9% year-over-year to $1.3 million; the TTM figure through Dec 2020 stood at $1.3 million (down 89.96% YoY), while the FY2020 annual figure was $1.3 million, down 89.96% from the prior year.
• Preferred Dividend Payments slipped to $1.3 million in Q1 2020 per BEAM's latest filing, from $3.3 million in the prior quarter.
• Across five years, Preferred Dividend Payments topped out at $3.3 million in Q4 2019 and bottomed at $1.3 million in Q1 2020.